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siFKBP52Immunophilins are FK506-binding proteins that have been involved in the regulation of calcium homeostasis,
either by modulating Ca2+ channels located in the plasma membrane or in the rough endoplasmic reticulum
(RE). We have investigated whether immunophilins would participate in the regulation of stored-operated
Ca2+ entry (SOCE) in human platelets and MEG 01. Both cell types were loaded with fura-2 for determining
cytosolic calcium concentration changes ([Ca2+]c), or stimulated and ﬁxed to evaluate the protein interaction
proﬁle by performing immunoprecipitation and western blotting. We have found that incubation of platelets
with FK506 increases Ca2+ mobilization. Thapsigargin (TG)-evoked, Thr-evoked SOCE and TG-evoked Mn2+
entry resulted in signiﬁcant reduction by treatment of platelets with immunophilin antagonists. We conﬁrmed
by immunoprecipitation that immunophilins interact with transient receptor potential channel 1 (TRPC1) and
Orai1 in human platelets. FK506 and rapamycin reduced the association between TRPC1 and Orai1 with FK506
binding protein (52) (FKBP52) in human platelets, and between TRPC1 and the type II IP3R, which association
is known to be crucial for the maintenance of SOCE in human platelets. FKBP52 role in SOCE activation was
conﬁrmed by silencing FKBP52 using SiRNA FKBP52 in MEG 01 as demonstrated by single cell conﬁguration
imaging technique. TRPC1 silencing and depletion of cell of TRPC1 and FKBP52 simultaneously, impair activation
of SOCE evoked by TG in MEG 01. Finally, in MEG 01 incubated with FK506 we observed a reduction in TRPC1/
FKBP52 coupling, and similarly, FKBP52 silencing reduced the association between IP3R type II and TRPC1 during
SOCE. All together, these results demonstrate that immunophilins participate in the regulation of SOCE in human
platelets.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Stored-operated Ca2+ entry (SOCE) is a major mechanism for
conducting Ca2+ inﬂux in human platelets, as well as in other
non-excitable cell types [1–4]. In platelets, association of STIM1 and
IP3RII located in the membranes of internal stores, with Ca2+ channels
expressed in the plasma membrane, like Orai1 and TRPC1, promotes
SOCE [4–8]. In human platelets, several members of the canonical tran-
sient receptor potential channels, such as TRPC1, TRPC4 [6,8,9], TRPC3philin; FKBP52, FK506 bind-
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l rights reserved.and TRPC6 [6,10] have been reported to associate to Orai1; thus
conforming heteromultimeric channel complexes, which have been
shown to present different sensitivity to store depletion, which relies
on STIM1 function [11–13].
Immunophilin family groups proteins with chaperone activity
(PPIase-activity) have been classiﬁed into three main subfamilies:
cyclophilins (Cyps) [14,15], that bind cyclosporin A (CsA) [14,16,17];
immunophilins (FK506-binding proteins or FKBPs) inhibited by
FK506 (tacrolimus) and rapamycin (sirolimus), both structurally
unrelated to cyclosporin A (CsA); and FCBPs (FK506- and cyclosporin-
binding proteins) that bind both macrolides [16]. In human lympho-
cytes and other cell types, including human platelets, impairment of
immunophilin activity evokes deregulation of intracellular Ca2+
homeostasis. In this sense, calstabin 12 (FKBP12.6) silencing in the
mdx mice model evoked alteration of Ca2+ leak from the endoplasmic
reticulum (ER), which resulted in a weak myocyte contraction that is
characteristic of Duchene's disease [18,19]. In addition, several
Ca2+-handling proteins, which activity is crucial for cellular processes,
have been shown to be compromised in the presence of antagonists of
the immunophilin subfamily, such as cyclophilins. Treatment of cells
with these antagonists impaired, for instance, the activity of the
sarcoendoplasmic reticulum Ca2+ ATPase (SERCA) in human platelets
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Finally, there is scarce information regarding the participation of
immunophilins in SOCE, or whether they associate with SOC channels
[24,25]. Hence, taking into account that some FKBP subfamily mem-
bers regulate the permeability of intracellular Ca2+ channels, such as
ryanodine receptors and IP3 receptors [19,23], here we address the
role of FKBPs in SOCE in human platelets and MEG01.
2. Material and methods
2.1. Materials
Apyrase (grade VII), aspirin, thrombin (Thr), dithiothreitol (DTT),
thapsigargin (TG), sodium dodecyl sulphate (SDS), ionic detergent
tween 20 (Tween-20), cypermethrin, ECL reagents and bovine
serum albumin (BSA), rabbit anti-Orai1 antibody (c-terminal) were
from Sigma (Madrid, Spain). FK506, cyclosporin A and rapamycin
were from Selleck Chemical® (Huston, Texas, U. S. A). Protein
A-agarose was from Upstate Biotechnology (Lake Placid, NY, U.S.A.).
Anti-hTRPC1 antibody, Anti-CN (PP2B) antibody, anti-FKBP52 anti-
body, anti-IP3R type II antibody and SiRNA against FKBP52 were
from (SantaCruz biotechnology®). ShRNA against TRPC1 was kindly
provided by Dr. Ambudkar. MEG 01 culture medium RPMI, strepto-
mycin/penicillin and other elements required for MEG 01 cell culture
and protein silencing (KIT-C Amaxa) were purchased from LONZA®.
Horseradish peroxide-conjugated anti-rabbit or anti-mouse IgG anti-
bodies, hyperﬁlm ECL and molecular weight markers were from GE
Healthcare UK Ltd (Chalfont St. Giles, UK). All other reagents were
of analytical grade.
2.2. Platelet preparation
Fura-2-loaded platelets were prepared as described previously
[2–4]. Brieﬂy, blood was obtained from healthy drug-free volunteers
and mixed with one-sixth volume of acid/citrate dextrose anticoag-
ulant containing (in mM): 85 sodium citrate, 78 citric acid and 111
D-glucose. Platelet-rich plasma was then prepared by centrifugation
for 5 min at 700×g and then aspirin (100 μM) and apyrase (40 μg/mL)
were added. For intracellular Ca2+ concentration measurement, the
platelet-rich plasma was incubated at 37°C with 2 μM of fura-2/AM
for 45 min. Platelets were collected by centrifugation at 350×g for
20 min, then resuspended in HEPES-buffered saline (HBS), and ﬁnally
subjected to the appropriate stimulation protocol as required. HBS con-
tains (in mM): 145 NaCl, 10 HEPES, 10 D-glucose, 5 KCl, 1 MgSO4, pH
7.45 and supplemented with 0.1% w/v bovine serum albumin and
40 μg/mL apyrase.
2.3. Cell culture and protein silencing procedure
The human megakaryoblastic cell line, MEG 01 cells, was obtained
from ATCC (Manassas, VA, USA) and cultured at 37 °C with a 5% CO2
in RPMI media, supplemented with 10% fetal calf serum, 2 mM
L-glutamine and a cocktail of penicillin and streptomycin as recom-
mended by the supplier. Cells were transiently transfected with
SiRNA against FKBP52, or with ShRNA against TRPC1, and with
both ShTRPC1 and SiFKBP52 simultaneously, using the kit-C and
Amaxa Nucleofection system®, and following the manufacturer's
instructions which in our hand have been previously shown to
obtain efﬁcient results [26]. Transfected MEG 01 cells were used
72 h after transfection upon ensuring by western blotting that
targeted protein expression was efﬁciently reduced.
2.4. Measurement of cytosolic free Ca2+ concentration ([Ca2+]c)
Fluorescence was recorded from 2 mL aliquots of magnetical-
ly stirred platelet suspension (108 cells/mL) at 37 °C using aspectrophotometer (Cary Eclipse, Varian, Madrid) with excita-
tion wavelengths of 340 and 380 nm and emission at 510 nm.
Changes in [Ca2+]c were monitored using the fura-2 340/380
ﬂuorescence ratio and calibrated according to the method of
Grynkiewicz [27]. Alternatively, MEG 01 cells were incubated
for 30 min with 2 μM of fura-2/AM at room temperature and
then centrifuged for 2 min at 100×g, and resuspended in fresh
HBS medium supplemented with 50 μM of CaCl2. MEG 01 cells
were then transferred to a perfusion chamber that was placed
under an inverted microscope. Changes in fura-2 ﬂuorescence
as result of changes in the [Ca2+]c in MEG 01 cells were moni-
tored using a single-cell conﬁguration equipment and were
processed using Aquacosmos software (Hamamatsu ®). Data
are expressed as change in ﬂuorescence after the addition of
different stimulus (Fn) divided by ﬂuorescence emitted by the
cells under resting conditions (F0). Additionally, Mn2+-induced
quenching of fura-2 ﬂuorescence excited at 360 nm was used as
a surrogate for monitoring Ca2+ entry, since both cations share
the same channels and mechanisms for entering platelets, as
previously described [28]. Data in the histogram are expressed
as percentage of the changes in the decay rate at 360 nm evoked
by fura-2-ﬂuorescence quenching of Mn2+, after addition of the
stimulus (Fn) and compared to control non-stimulated cells (F0).
2.5. Immunoprecipitation and western blotting
The immunoprecipitation and western blotting were performed
as described previously [2–4]. Brieﬂy, 250 μL aliquots of platelet
suspension (109 cells/mL), MEG 01 cells wt (10×106 cells/mL)
and MEG 01 cells transfected with the FKBP52 Si RNA or TRPC1
Sh RNA, or both RNAs, were then stimulated and lysed by mixing
with an equal volume of lysis buffer, RIPA at pH 7.2, that contains;
316 mM NaCl, 20 mM Tris, 2 mM EGTA, 0.2% SDS, 2% sodium
deoxycholate, 2% triton X-100, 2 mM Na3VO4, 2 mM phenylmethyl-
sulfonyl ﬂuoride, 100 μg/mL leupeptin and 10 mM benzamidine.
Aliquots of platelet and MEG 01 cell lysates (500 μL) were immu-
noprecipitated by incubating cells with 2 μg/mL of anti-IP3R type
II, anti-FKBP52, anti-CN and 25 μL of protein A-agarose, overnight
at 4 °C and placed in a rocking platform. The immunoprecipitates
were resolved by 10 % SDS-PAGE and separated proteins were
electrophoretically transferred onto nitrocellulose membranes for
subsequent probing. Blots were incubated overnight with 10%
(w/v) BSA or skimmed milk in tris-buffered saline with 0.1 %
Tween 20 (TBST) to block residual protein binding sites. Immuno-
detection was achieved using the anti-TRPC1 polyclonal antibody
diluted 1:200 in TBST (BSA), anti-FKBP52 diluted 1:200 in TBST
(skimmed milk) and incubated for 2 h, or using an anti-Orai1
antibody incubated overnight at 4 °C and diluted 1:1000 in TBST
(BSA). The primary antibody was removed and blots were washed
six times for 5 min each with TBST. To detect the primary anti-
body, blots were incubated with the appropriate horseradish
peroxidase-conjugated secondary antibody diluted from 1:2500
to 1:10000 in TBST (BSA or skimmed milk), depending of the
primary antibody used, and then exposed to enhanced chemilumi-
nescence reagents for 4 min. Blots were then exposed to a photo-
graphic ﬁlm. The density of bands on the ﬁlm was measured using
the Image J free software from NIH. Stripping of the membranes
and reprobing using anti-IP3RII, anti-CN, and anti-FKBP52, was
done to corroborate that similar amount of protein was loaded in
each gel lane.
2.6. Statistical analysis
Analysis of statistical signiﬁcance was performed using Student's
unpaired t-test and only values with pb0.05 were accepted as
signiﬁcant.
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3.1. FK506 alters Ca2+ leakage and active Ca2+ release from intracellu-
lar stores induced by agonists in human platelets
Treatment of human platelets in a Ca2+-free medium with the
sarco-endoplasmic reticulum Ca2+ ATPase (SERCA) blocker, thapsigargin
(TG) or with the physiological agonist thrombin (Thr), resulted in
sustained or transient increase in [Ca2+]c, respectively (Fig. 1A–B).
As shown in Fig. 1A, incubation of plateletswith the immunophilin antag-
onist, FK506, increased TG- and Thr-evoked Ca2+ release from the intra-
cellular pools. The effect of FK506 pretreatment for 5 min was dose-
dependent. Thus, we found that TG-evoked Ca2+ release was increased
by 36.6±17.8% using 10 μM of FK506 (Fig. 1A, dark-gray dotted line;
pb0.05; n=6) and 85.4±11.6% in cells incubated with 50 μM (Fig.
1A, dark-gray solid trace; pb0.001; n=6). We have also found that
in human platelets stimulated with TG, EC50 of FK506 was 9.75 μM.
Similarly, active Ca2+ release from the stores evoked by thrombin (Thr,
0.1 U/mL) was enhanced in the presence of FK506 (20.63±4.9% using
10 μM; Fig. 1B, dark-gray dotted line; pb0.05; n=6; and 65.02±22.4%
in the presence of 50 μM; Fig. 1B, dark-gray solid line; pb0.01; n=6).
3.2. FK506 alters TG- and Thr-induced Ca2+ entry in human platelets
As shown in Fig. 1A–B, Ca2+ entry induced by incubating human
platelets either with TG or Thr, was altered in platelets previously
incubated for 5 min with FK506. Incubation of human platelets with
increased concentration of FK506 (0.01–100 μM) evoked a dose-
dependent reduction in TG-evoked SOCE. IC50 of FK506 in SOCE
observed was 18.5 μM. Furthermore, FK506 also altered Thr-evoked
SOCE. In this case, different results were obtained depending of the
FK506 dose used, thus platelets incubation with 10 μM of FK506
enhanced by 38.2±12.5 % in Thr-evoked SOCE (pb0.01; n=6), while
50 μM FK506 induced a signiﬁcant attenuation of 67.8±11.2% in
Thr-evoked Ca2+-entry (pb0.001; n=8).
In order to further explore whether FK506 alters SOCE, experiments
in the absence of extracellular Ca2+ (EGTA 100 μM was added), but in
the presence of extracellular MnCl2 (200 μM) were performed. Mn2+
extrusion from the cellular cytosol through PMCA and Na+/Ca2+ is
very low, as previously reported, therefore by using this cation we ex-
cluded possible interferences with Ca2+ extrusion mechanisms during
cation entry monitoring [29,30]. As observed in Fig. 1C, incubation of
platelets with 50 μM of FK506 signiﬁcantly reduced TG-evoked Mn2+
entry by 26.7±10.7% (pb0.01; n=6).
3.3. Immunophilins regulate SOCE by a calcineurin (CN)-independent
signaling pathway
Immunophilin inhibitors have been commonly referred in the
literature as speciﬁc inhibitors of calcineurin, moreover their actual
inhibitory effect that is based on a previous binding and subse-
quently inhibition of FKBPs, like FKBP12 or FKBP52, has remained
unconsidered [22,23] [31]. However, it is widely accepted in the
literature that FK506, upon binding to its target immunophilins,
acquire a three-dimensional conformation that adapts inside the
functional domain of CN inhibiting its activity [32]. Rapamycin is
another immunophilin subfamily antagonist that upon complexingFig. 1. Effect of FK506 on cytosolic calcium homeostasis induced by TG and thrombin in human p
was added as indicated by arrowhead), and preincubated for 5 min at 37 °C in the absenc
(light-doted and dark solid-gray traces, respectively). Cells were then stimulated with TG (200
medium to visualize calcium entry. (C–D) Platelets were suspended in calcium free-HBS and
(500 nM; D, gray trace) or their respective vehicles (black traces) and upon addition of MnCl
Changes in fura-2 ﬂuorescence were monitored using the 340/380 nm ratio and calibrated in
fura-2 is used as surrogated of Ca2+ to monitor SOCE activation which is represented as ﬂuo
mean±SEM of six to eight separate experiments and they are presented as percentage of contto FBKPs, reduces mTOR activity, without affecting CN activity;
therefore, we have used rapamycin to ascertain whether CN is in-
volved in SOCE. As shown in Fig. 1D, rapamycin treatment reduced
Mn2+ entry by 13.1±8.2 % (pb0.05; n=6). Impairment of SOCE by
rapamycin was then corroborated by performing experiments in
the presence of 300 μM of CaCl2. Under these experimental condi-
tions, rapamycin administration signiﬁcantly reduced TG-evoked
Ca2+-entry by 19.5±9.4% (Fig. 2A; pb0.05; n=6), and contrary
to FK506 the Ca2+ leak from stores resulted in inhibition by
11.1±4.8% (pb0.05; n=6).
Inhibition of the other main immunophilin subfamily, cyclophilins,
by incubating platelets with CsA (50 μM) for 5 min at 37 °C, also
reduced TG-activated SOCE by 32.4±11.0% (Fig. 2B; pb0.01; n=6),
while an increase on TG-evoked Ca2+ release of 36.6±25.9% was ob-
served (pb0.05; n=6), perhaps due to more rapid inhibition of
SERCA2b activity, as previously described [20].
Alternatively, incubation of human platelets with the speciﬁc CN
inhibitor, cypermethrin (100 nM) for 30 min, whose action mecha-
nism is different from that reported for immunophilin antagonist,
reduced TG-induced SOCE by 14.0±7.8% (Fig. 2C; pb0.05; n=6),
but without altering Ca2+ release from the stores. Finally, demonstra-
tion of a CN-independent role of immunophilins in SOCE activation is
presented in Fig. 2D, where human platelets were incubated for
30 min with cypermethrin (100 nM)+rapamycin (500 nM), or
with cypermethrin (100 nM)+FK506 (50 μM; for the latest 5 min
previous to [Ca2+]c determination). As demonstrated by comparing
Fig. 2C and D, combined treatment with CN antagonist and
immunophilin antagonists evoked bigger SOCE inhibition than
cypermethrin alone (51.7±5.8 % and 35.0±5.9%, respectively;
pb0.001; n=4). As shown in Fig. 2D, only in the presence of FK506
a signiﬁcant increase in TG Ca2+ release was observed (212.5±
20.8%, light-gray traces; pb0.001; n=4). Hence, our results indicate
that despite CN is regulating SOCE, an alternative regulatory pathway
that relies on immunophilin activity is also present in human platelets.
3.4. Immunophilins are required for complexing Ca2+ channels during
SOCE activation in platelets
Studies on the role of TRPC1 in SOCE are controversial.While studies
in platelets from KOmicewhere TRPC1 reported no differences in SOCE
activation [33], several others independent groups have demonstrated
that TRPC1, alone or coupled to Orai1 and IP3R type II, is an important
elements for the activation and maintenance of SOCE in platelets and
other cell types [34–36]. Here, we have evaluated the role of FKBPs in
the formation of these proteins complexes by performing immuno-
precipitations. Brieﬂy, human platelets were treated at 37 °C for 5 min
with FK506 (50 μM) or left untreated, and then stimulated in a
Ca2+-free medium for 1 min with Thr (0.1 U/mL). As shown in
Fig. 3A, stimulation of human platelets with Thr (0.1 U/mL) evokes
the formation of TRPC1/type II IP3R complexes. The generation of this
complex was attenuated by 40.2±21.7% (pb0.05; n=4) in platelets
previously incubated for 5 min with FK506 (50 μM; Fig. 3A and histo-
grambelow). Additionally, in platelets treated for 30 minwith the vehi-
cle or rapamycin (500 nM) and then stimulated with Thr (Fig. 3B), the
coupling between both elements was reduced by 27.9±2.5% (pb0.01;
n=4). Furthermore, incubation of human platelets with FK506
(50 μM) equally impaired the association between TRPC1 and CNlatelets. (A–B)Human platelets were suspended in a Ca2+-freemedium (100 μMof EGTA
e (solid black traces) or presence of increased concentrations (0.01–100 μM) of FK506
nM; A) or Thr (0.1 U/mL; B) and 3 min later 300 μM of CaCl2 was added to extracellular
incubated for 5 min with FK506 (50 μM; C, gray trace) or for 30 min with rapamycin
2 (200 μM) platelets were stimulated with TG to enhance the opening of SOCE channels.
terms of [Ca2+]c. Alternatively, Mn2+ quenching properties over 360 nm wavelength of
rescence initial (F0) divided by ﬂuorescence upon TG stimulation. Histograms represent
rol. *, **, and *** represent pb0.05, pb0.01 and pb0.001, with respect to control platelets.
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FK506 but stimulated with Thr (Fig. 3C and histogram below; pb0.05;
n=4). As expected, treatment with rapamycin (500 nM) for 30 min
was without effect (Fig. 3D and histogram below; pb0.05; n=4). Fur-
thermore, we have found that treatment of platelets with FK506 and
rapamycin prevented the increase in the association between FKBP52
and TRPC1 in platelets stimulated with Thr (0.1 U/mL), which in cells
non-treated with FK506 was enhanced by 22.8±16.9% (Fig. 3E;*,
pb0.05; n=4).
On the other hand, Orai1 have recently been described in human
platelets and megakaryocytes as a key element during the activation
of SOCE [11,37–39]. Hence, we have evaluated whether immunophilins
might be associated to Orai1 during calcium entry in human platelets.
As shown in Fig. 4A, we have found that in resting conditions FKBP52
complexed to Orai1, and upon platelet stimulation with Thr, FKBP52/
Orai1 interaction was enhanced by 57.2±34.7% (pb0.05; n=4). As
reported above for the TRPC1/FKBP52 complex, platelets preincubation
for 5 min with FK506 (50 μM) evoked a signiﬁcant reduction in
FKBP52/Orai1 complex, both in resting conditions (25.5±10.1%; ***,
pb0.001; n=4), and upon stimulation with Thr (98.3±17.6%; $$$,
pb0.001; n=4). Similarly, incubation with rapamycin (500 nM) for
30 min reduced by 86.3±9.5% the coupling between FKBP52 and
Orai1 induced by Thr in these cells ($$$, pb0.001; n=4).
3.5. FKBP52 is required for SOCE activation in human platelets and MEG
01 cells
In order to corroborate the involvement of FKBP52 in SOCE, we
have silenced FKBP52 in MEG 01 cells, which is a megakaryoblastic
cell line that in presence of thrombopoietin and under the adequate
experimental conditions have been derived into platelets [40]. It
has been reported that MEG 01 cells express most of the elements
that participates in calcium homeostasis and in particular that have
been previously described participating in SOCE activation mechanism
in human platelets [41–45]. Hence, by using Amaxa® nucleofector
and Si RNA FKBP52 (2 μg/mL), we were able to reduce efﬁciently the
expression of FKBP52 upon 72 h of transfection procedure, as revealed
Western blotting (see Fig. 5A left-hand side image). Furthermore, we
have also silenced TRPC1 alone using a Sh RNA TRPC1 (see Fig. 5A
right-hand side image). As shown in Fig. 5B, single-cell imaging exper-
iments using MEG 01 cells with fura-2 revealed that silencing of
FKBP52, TRPC1 or both reduced signiﬁcantly TG-evoked SOCE by
25.4±10.1%; pb0.05; n=4), 33.0±4.0% (pb0.01; n=4) and 46.2±
18.3% (pb0.01; n=4), respectively. Transfection itself was without
effect on Ca2+ accumulation inside the intracellular stores, as demon-
strated by the fact that irrelevant alteration in calcium leak in response
to TG is found upon comparing the areas under the curves as described
in the Material and methods section (Fig. 5B and C).
Additionally,MEG 01 cells transfectedwith Si RNA FKBP52 and incu-
bated for 5 min with FK506 showed reduced TG-evoked Ca2+-release
(61.6±14.1%; pb0,001; n=4; Fig. 5C) and SOCE (32,3±21.3%;
pb0,01; n=4; Fig. 5C).
Finally, we have observed that in MEG 01 cells, FKBP52/Orai1
complex is detected under resting conditions and it is signiﬁcantly
enhanced by 35.1±15.1% upon stimulation with TG for 1 min
(Fig. 4B; pb0.01; n=6), and as occurred in platelets, preincubation
with FK506 (50 uM for 5 min) signiﬁcantly reduces FKBP52/Orai 1
complex generated by stimulating with TG (200 nM) (61.9±28.4%;
pb0.01; n=6). Additionally, we have observed lack or very lowFig. 2. Immunophilins participate in SOCE activation by CN-dependent but also CN-indepe
quently incubated at 37 °C for 30 min with either rapamycin (500 nM; A) or cypermethi
and cypermethrin+FK506 (50 μM; D, light-solid gray trace). Alternatively, platelets are in
different conditions was over, platelets were stimulated with TG (200 nM) in a calcium
CaCl2 (300 μM) was added to visualized calcium entry. Changes in fura-2 ﬂuorescence wer
representative of four to six independent experiments. *, **, and *** represents pb0.05, pb0association between TRPC1-FKBP52 in MEG 01 cells under resting con-
dition, but a very signiﬁcant TRPC1/FKBP52 coupling was found upon
SOCE stimulationwith TG (51.5±20.2%; pb0.05; n=4; Fig. 5D). Treat-
ment of MEG 01 cells with 50 μM FK506 for 5 min reduced by 72.8±
17.1% the TRPC1/FKBP52 association (pb0.001; n=4). We further
explore the role of FKBP52 in generation of SOCE-associated com-
plexes, by silencing FKBP52, which reduced by 127.2±40.7%
TG-evoked type II IP3R/TRPC1 coupling as compared to controls
(Fig. 5E; pb0.001; n=4), thus revealing a direct role in the regula-
tion of TRPC1 function in MEG 01, as occurred in platelets.4. Discussion
Immunophilin inhibitors have been often considered as speciﬁc
CN activity antagonists [22,23,31], since immunophilins-FK506 and
CsA-immunophilins complexes inhibits CN [46], despite the fact that
FK506 or CsA speciﬁcally target the peptidyl-prolyl isomerase active
domain of immunophilins. Hence, in the present study we have eval-
uated the possible participation of immunophilins in intracellular
Ca2+ homeostasis in human platelets independently of CN.
The increasing effect induced by FK506 on Ca2+ release may be at-
tributed to the activity of CaM- and CN-dependent phosphorylation/
dephosphorylation mechanisms of ER-resident Ca2+ channels as pre-
viously reported in other cells types [47–50]. However in human
platelets, as observed in Fig. 3D, despite CN might participate in the
regulation of Ca2+ leak from the stores, a CN independent Ca2+
leak evoked by FK506 is demonstrated, by using cypermethrin, a CN
antagonist, which was reported without effect in Ca2+ leak. Under
these experimental conditions, FK506 was still able to further in-
crease Ca2+ leakage in platelets stimulated with TG. Nevertheless, a
regulatory role for CN on Ca2+ leakage is probably present in
human platelets, due to the signiﬁcant differences observed in Ca2+
leakage between cell treated with cypermethrin and rapamycin and
compared with platelets treated with rapamycin alone (see Fig. 3A
vs D). In this sense, CN-dependent mechanisms might be also present
in MEG 01 cells, where treatments of Si RNA FKBP52 transfected cells
with FK506 showed a signiﬁcant reduction in the Ca2+ leak upon
stimulation with TG, indicative of a role for FKBP52 Ca2+ leak. Fur-
thermore, participation of other immunophilins cannot be rule out.
Our results concerning SOCE regulation by immunophilins are
consistent with previous observations in other cell models [31,51].
Nevertheless, other authors have considered a unique retrograde
CN-dependent mechanism for regulating Ca2+ entry activation. The
mechanisms currently proposed suggest that only in conditions where
[Ca2+]c reaches a critical value, CN may evoke the activation of
non-capacitative arachidonic acid-dependent Ca2+ channels (ARC).
Furthermore, these authors contemplate the possibility of an alternative
participation of immunophilins, different from the CN pathway in
HEK293 cells [31]. In human platelets, as shown in Fig. 2, an alternative
CN-independent pathway might also coexist, since as we have shown,
FK506 has a dual effect in SOCE depending on the concentration used
(see Fig. 1), while rapamycin incubation also inhibits SOCE, and this
effect has been linked to inhibition of the mTOR (AKT/PKB) pathway
instead of the classically proposed CN mechanism [17,52]. The latest
observations in MEG 01 and platelets suggest that FKBP52, or other
immunophilin activities, like FKBP12, are impaired by complexing
with their target drugs, such as FK506 or rapamycin, being enough to
alter SOCE in our cellular lineage.ndent signaling pathways. Fura-2 loaded platelets were suspended in HBS and subse-
n (100 nM; C); or a combination of cypermethrin+rapamycin (D, dark-doted trace)
cubated for 5 min with cyclosporin A (CsA, 50 μM; B). Once incubation times with the
free-HBS (EGTA 100 μM was added as indicated the by arrowhead) and 4 min later
e monitored using the 340/380 nm ratio and calibrated in terms of [Ca2+]c. Traces are
.01 and pb0.001, with respect to control platelets.
658 E. López et al. / Biochimica et Biophysica Acta 1833 (2013) 652–662Despite that other groups have presented evidences against the
participation of TRPCs and in particular TRPC1 in SOCE, using proto-
cols that include TRPC1-knockout mice model [33], here we showthat in MEG 01 cells TRPC1 silencing has a clear negative effect on
SOCE, thus demonstrating that, as previously reported in human
platelets and in several other cell types, TRPC1 has an important
Fig. 4. Platelets treatment with FK506 and rapamycin impairs FKBP52 association to Orai1 in human platelets and MEG 01 cells. Human platelets (A) and MEG 01 (B) suspended in
free-Ca2+ medium (EGTA, 100 μM) were incubated for 5 min at 37 °C with FK506 (50 μM) or for 30 min with rapamycin (500 nM) as indicated. Cells were then stimulated for 1 min
with Thr (0.1 U/mL, A) or TG (200 nM; B) to induce Ca2+ entry, and then they were ﬁxed by mixing for 10 min with equal volume of ice-cold RIPA. FKBP52 was immunoprecipitated
from platelet lysates by incubating overnight at 4 °C with 2 μgr/mL of speciﬁc anti-FKBP52 antibody as described under Material andmethods. Western blotting was done by incubation
with a speciﬁc anti-Orai1 antibody diluted 1:1000 in blocking buffer overnight. Reproving of the membranes was done using the speciﬁc anti-FKBP52 antibody for 2 h diluted 1:200 in
blocking buffer containing skimmedmilk. Images shown are representative of four independent experiment and histograms represents the percentage of coupling as compared to control
and expressed as means and standard errors. *, pb0.05, **, pb0.01 and ***, pb0.001, as compared to untreated resting cells.
659E. López et al. / Biochimica et Biophysica Acta 1833 (2013) 652–662role in SOCE [34–36]. Experimental data, obtained by our group and
others, suggest that TRPC1 is a relevant element of the macromolecu-
lar complex newly generated during SOCE [6,11,53].
Recently studies have described by using nuclear magnetic reso-
nance (NMR) exchange spectroscopy, a region within TRPC1 structure,
which has been designated as TRP box 2. This region has been described
as a suitable target region for the immunophilin-PPIase activity. It has
been also suggested that after conformational changes induced by
FKBP52 or FKBP12, consisting on isomerization of the proline residues
found within this target region, TRPC1 would be unrecognized by
Homer. Homer has recently been described as a structural element
that would support the complexes of TRPC1 during SOCE activation.
On the other hand, it has also being involved in SOCE inhibition due to
its complexing to an extra homer-binding domain identiﬁed in TRPC1
structure [54]. Hence, we suggest that removal of immunophilins
from TRPC1 heteromultimeric complex disturbs the fragile stoichi-
ometry of the macromolecular complex generated during activation
of SOCE, being this role independently of calcineurin activity. Evi-
dences of this role of immunophilin in the generation of the macro-
molecular complexes are presented in Fig. 4, where both, FK506 and
rapamycin signiﬁcantly block the coupling between TRPC1 and typeFig. 3. Immunophilins regulate the generation of the macromolecular TRPC1-complex d
calcium-free medium (EGTA, 100 μM) were incubated for 5 min at 37 °C with FK506 (50 μM
were then stimulated for 1 min with Thr (0.1 U/mL) and lysed by mixing for 10 min with
FKBP52 was achieved using 2 μgr/mL of speciﬁc antibodies as described under Material an
BSA (1:200) for 2 h was done to analyze coupling formation. Membrane reproving with t
was loaded in all gel lanes. Histograms below show the percentage of association of the d
experimental conditions, and compared to platelets left untreated but stimulated with Th
with respect to untreated but Thr-stimulated platelets. Images are representative of additioII IP3R. Similarly in MEG 01 cells transfected with Si RNA FKBP52, a
reduction in TRPC1/type II IP3R was also observed. Furthermore, as
mentioned above, TRP regulationbyphysical interaction of immunophilin
members has already been reported mainly linked to non-capacitative
Ca2+ channels, such as TRPL, TRPV, and TRPC6. Here, we have shown
for the very ﬁrst time that FKBP52 and TRPC1 interaction occurs in
human platelets and in MEG 01 cells, and how these complexes are im-
paired by treating human platelets with the FKBP inhibitors, FK506 and
rapamycin. In other cell models, FKBP12 associates with TRPC3 and
TRPC6, and FKBP52binds to TRPC1, TRPC4 andTRPC5, hence participation
of additional FKBPs during SOCE activation in human platelets cannot be
excluded, since in MEG 01 where FKBP52 was silenced FK506 was still
able to evoke a signiﬁcant reduction of SOCE.
To our knowledge this is the ﬁrst description that Orai1 interacts
with immunophilin members, and this mechanism is found not only
in the platelet but also in megakaryoblastic cell line, MEG 01 hence,
indicating that this mechanism is not exclusive of differentiated
cells like platelets.
Finally, alternative explanation for FKBP52-dependent regulatory
mechanism of SOCE would involve a competitive association with
the scaffolding protein homer, that has been recently shown touring Thr-evoked calcium entry in human platelets. Human platelets suspended in
; A, C and E) or for 30 min with rapamycin (500 nM; B, D and E), as indicated. Platelets
equal volume of ice-cold RIPA. Immunoprecipitation of either the type II IP3R, CN and
d methods. Western blotting using an anti-TRPC1 antibody diluted in TBST containing
he antibody used for immunoprecipitation conﬁrmed that similar amount of protein
ifferent proteins with TRPC1 in Thr-stimulated platelets incubated under the different
r. *, pb0.05 and **, pb0.01 with respect to resting untreated platelets and $, pb0.05
nal four independent experiments.
660 E. López et al. / Biochimica et Biophysica Acta 1833 (2013) 652–662interact with TRPC1 and Orai1 and regulates SOCE in several cell
types including platelets [55–58]. In this sense, in neurons it has re-
cently been shown that homer shares a binding region with FKBP52
that is localized within the TRPC1 C-terminal domain, however theexistence of such a competence has not been conﬁrmed in human
platelets yet and to our knowledge would deserved future investiga-
tion according to the relevance of the result concerning FKBP52
presented here [59].
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